FTC Must Tackle Anti-Competitive Drug Rebate Practices
Pharmaceutical manufacturers have implemented a strategy to block and delay entry of new innovative drugs from the market through a contracting practice that creates what is known as a "rebate wall"...To view the full article, register now.
Already a subscriber? Click here to view full article